![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 22, 16941-16947, June 2, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Microglia are macrophage-like immune system cells
found in the brain. They are associated with Alzheimer's Disease
plaques, which contain fibrillar
Effects of Incorporation of Immunoglobulin G and Complement
Component C1q on Uptake and Degradation of Alzheimer's Disease Amyloid
Fibrils by Microglia*
,
§, and
¶
Department of Biochemistry, Weill Medical
College of Cornell University, New York, New York 10021 and the
§ Department of Pathology, College of Physicians and
Surgeons, Columbia University, New York, New York 10032
-amyloid (fA
) and other
components such as complement proteins. We have shown previously that
murine microglia bind and internalize fA
microaggregates via the
type A scavenger receptor, but degradation of internalized fA
is
significantly slower than normal degradation. In this study, we
compared internalization by microglia of fA
microaggregates to that
of anti-A
-antibody-coated fA
(IgG-fA
) microaggregates and
found that the uptake of the latter is increased by about 1.5-fold
versus unmodified fA
. The endocytic trafficking of
IgG-fA
is similar to that of fA
microaggregates, following an
endosomal/lysosomal pathway. We also compared the internalization of
fA
microaggregates to that of complement protein, C1q-coated fA
microaggregates, and found that the levels of uptake are also increased
by about 1.5-fold. Rates of degradation of both types of modified fA
microaggregates are unchanged compared with unmodified fA
microaggregates. We demonstrated by blocking studies that
internalization of IgG-fA
is mediated by Fc receptors. These data
suggest that, in vivo, several different microglial receptors may play a part in internalizing fA
, but the involvement of other receptors may not increase the degradation of fA
.
*
This work was supported by National Institutes of Health
Grant NS34761.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
A. Majumdar, D. Cruz, N. Asamoah, A. Buxbaum, I. Sohar, P. Lobel, and F. R. Maxfield Activation of Microglia Acidifies Lysosomes and Leads to Degradation of Alzheimer Amyloid Fibrils Mol. Biol. Cell, April 1, 2007; 18(4): 1490 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tahara, H.-D. Kim, J.-J. Jin, J. A. Maxwell, L. Li, and K.-i. Fukuchi Role of toll-like receptor signalling in A{beta} uptake and clearance Brain, November 1, 2006; 129(11): 3006 - 3019. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Patton, W. M. Kalback, C. L. Esh, T. A. Kokjohn, G. D. Van Vickle, D. C. Luehrs, Y.-M. Kuo, J. Lopez, D. Brune, I. Ferrer, et al. Amyloid-{beta} Peptide Remnants in AN-1792-Immunized Alzheimer's Disease Patients: A Biochemical Analysis Am. J. Pathol., September 1, 2006; 169(3): 1048 - 1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bi, M. Baudry, J. Liu, Y. Yao, L. Fu, F. Brucher, and G. Lynch Inhibition of Geranylgeranylation Mediates the Effects of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Inhibitors on Microglia J. Biol. Chem., November 12, 2004; 279(46): 48238 - 48245. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Koenigsknecht and G. Landreth Microglial Phagocytosis of Fibrillar {beta}-Amyloid through a {beta}1 Integrin-Dependent Mechanism J. Neurosci., November 3, 2004; 24(44): 9838 - 9846. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Gelinas, K. DaSilva, D. Fenili, P. St. George-Hyslop, and J. McLaurin Immunotherapy for Alzheimer's disease PNAS, October 5, 2004; 101(suppl_2): 14657 - 14662. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Fonseca, J. Zhou, M. Botto, and A. J. Tenner Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease J. Neurosci., July 21, 2004; 24(29): 6457 - 6465. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Das, V. Howard, N. Loosbrock, D. Dickson, M. P. Murphy, and T. E. Golde Amyloid-{beta} Immunization Effectively Reduces Amyloid Deposition in FcR{gamma}-/- Knock-Out Mice J. Neurosci., September 17, 2003; 23(24): 8532 - 8538. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Furlan, E. Brambilla, F. Sanvito, L. Roccatagliata, S. Olivieri, A. Bergami, S. Pluchino, A. Uccelli, G. Comi, and G. Martino Vaccination with amyloid-{beta} peptide induces autoimmune encephalomyelitis in C57/BL6 mice Brain, February 1, 2003; 126(2): 285 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. N. J. de Grey An Engineer's Approach to the Development of Real Anti-Aging Medicine Sci. Aging Knowl. Environ., January 8, 2003; 2003(1): vp1 - vp1. [Abstract] [Full Text] |
||||
![]() |
X. Song, S. Shapiro, D. L. Goldman, A. Casadevall, M. Scharff, and S. C. Lee Fc{gamma} Receptor I- and III-Mediated Macrophage Inflammatory Protein 1{alpha} Induction in Primary Human and Murine Microglia Infect. Immun., September 1, 2002; 70(9): 5177 - 5184. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Jantzen, K. E. Connor, G. DiCarlo, G. L. Wenk, J. L. Wallace, A. M. Rojiani, D. Coppola, D. Morgan, and M. N. Gordon Microglial Activation and beta -Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice J. Neurosci., March 15, 2002; 22(6): 2246 - 2254. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Webster, M. D. Galvan, E. Ferran, W. Garzon-Rodriguez, C. G. Glabe, and A. J. Tenner Antibody-Mediated Phagocytosis of the Amyloid {{beta}}-Peptide in Microglia Is Differentially Modulated by C1q J. Immunol., June 15, 2001; 166(12): 7496 - 7503. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |